Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1978 2
1979 3
1980 4
1981 2
1982 5
1983 5
1984 6
1985 9
1986 3
1987 7
1988 7
1989 11
1990 7
1991 11
1992 10
1993 12
1994 13
1995 18
1996 14
1997 20
1998 30
1999 31
2000 31
2001 37
2002 43
2003 43
2004 40
2005 32
2006 32
2007 62
2008 59
2009 52
2010 67
2011 60
2012 73
2013 81
2014 93
2015 83
2016 72
2017 69
2018 67
2019 71
2020 93
2021 85
2022 98
2023 92
2024 38

Text availability

Article attribute

Article type

Publication date

Search Results

1,623 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Unresectable Malignant Liver Neoplasm"
Page 1
Management of Hepatocellular Carcinoma: A Review.
Brown ZJ, Tsilimigras DI, Ruff SM, Mohseni A, Kamel IR, Cloyd JM, Pawlik TM. Brown ZJ, et al. JAMA Surg. 2023 Apr 1;158(4):410-420. doi: 10.1001/jamasurg.2022.7989. JAMA Surg. 2023. PMID: 36790767 Review.
OBSERVATIONS: HCC is a major health problem worldwide. The obesity epidemic has made nonalcoholic fatty liver disease a major risk factor for the development of HCC. Multiple societies, such as the American Association for the Study of Liver Diseases, the European A …
OBSERVATIONS: HCC is a major health problem worldwide. The obesity epidemic has made nonalcoholic fatty liver disease a major risk fa …
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification.
Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Chidambaranathan-Reghupaty S, et al. Adv Cancer Res. 2021;149:1-61. doi: 10.1016/bs.acr.2020.10.001. Epub 2020 Nov 28. Adv Cancer Res. 2021. PMID: 33579421 Free PMC article. Review.
When diagnosed at early stages, it is treatable with locoregional treatments including surgical resection, Radio-Frequency Ablation, Trans-Arterial Chemoembolization or liver transplantation. However, HCC is usually diagnosed at advanced stages when the tumor is unresec …
When diagnosed at early stages, it is treatable with locoregional treatments including surgical resection, Radio-Frequency Ablation, Trans-A …
Conversion therapy and maintenance therapy for primary hepatocellular carcinoma.
Zhou H, Song T. Zhou H, et al. Biosci Trends. 2021 Jul 6;15(3):155-160. doi: 10.5582/bst.2021.01091. Epub 2021 May 27. Biosci Trends. 2021. PMID: 34039818 Free article. Review.
The preferred treatment for hepatocellular carcinoma (HCC) is surgery, which is the only way to achieve long-term survival and even a cure. However, the vast majority of patients with liver cancer in China are already in the middle to advanced stage of the disease and no l …
The preferred treatment for hepatocellular carcinoma (HCC) is surgery, which is the only way to achieve long-term survival and even a cure. …
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Benson AB, D'Angelica MI, Abbott DE, Anaya DA, Anders R, Are C, Bachini M, Borad M, Brown D, Burgoyne A, Chahal P, Chang DT, Cloyd J, Covey AM, Glazer ES, Goyal L, Hawkins WG, Iyer R, Jacob R, Kelley RK, Kim R, Levine M, Palta M, Park JO, Raman S, Reddy S, Sahai V, Schefter T, Singh G, Stein S, Vauthey JN, Venook AP, Yopp A, McMillian NR, Hochstetler C, Darlow SD. Benson AB, et al. J Natl Compr Canc Netw. 2021 May 1;19(5):541-565. doi: 10.6004/jnccn.2021.0022. J Natl Compr Canc Netw. 2021. PMID: 34030131
Due to the multiple modalities that can be used to treat the disease and the complications that can arise from comorbid liver dysfunction, a multidisciplinary evaluation is essential for determining an optimal treatment strategy. ...In 2020, the combination of atezolizumab …
Due to the multiple modalities that can be used to treat the disease and the complications that can arise from comorbid liver dysfunc …
Goals and targets for personalized therapy for HCC.
Couri T, Pillai A. Couri T, et al. Hepatol Int. 2019 Mar;13(2):125-137. doi: 10.1007/s12072-018-9919-1. Epub 2019 Jan 1. Hepatol Int. 2019. PMID: 30600478 Review.
While the most widely used staging and treatment algorithm for HCC-the Barcelona Clinic Liver Cancer (BCLC) system-does not recommend systemic molecular therapy for early HCC, a variety of treatment options are available depending upon the stage of HCC at diagnosis. Determ …
While the most widely used staging and treatment algorithm for HCC-the Barcelona Clinic Liver Cancer (BCLC) system-does not recommend …
Pancreatic neuroendocrine tumors.
Perri G, Prakash LR, Katz MHG. Perri G, et al. Curr Opin Gastroenterol. 2019 Sep;35(5):468-477. doi: 10.1097/MOG.0000000000000571. Curr Opin Gastroenterol. 2019. PMID: 31306159 Review.
PURPOSE OF REVIEW: Pancreatic neuroendocrine tumors (pNETs) are a rare, heterogeneous group of pancreatic neoplasms with a wide range of malignant potential. They may manifest as noninfiltrative, slow-growing tumors, locally invasive masses, or even swiftly metastas …
PURPOSE OF REVIEW: Pancreatic neuroendocrine tumors (pNETs) are a rare, heterogeneous group of pancreatic neoplasms with a wide range …
Role of Hepatic Artery Infusion Chemotherapy in Treatment of Initially Unresectable Colorectal Liver Metastases: A Review.
Datta J, Narayan RR, Kemeny NE, D'Angelica MI. Datta J, et al. JAMA Surg. 2019 Aug 1;154(8):768-776. doi: 10.1001/jamasurg.2019.1694. JAMA Surg. 2019. PMID: 31188415 Review.
IMPORTANCE: Although liver metastasis develops in more than half of patients with colorectal cancer, only 15% to 20% of these patients have resectable liver metastasis at presentation. Moreover, patients with initially unresectable colorectal liver met …
IMPORTANCE: Although liver metastasis develops in more than half of patients with colorectal cancer, only 15% to 20% of these patient …
Hepatocellular carcinoma.
Llovet JM, Burroughs A, Bruix J. Llovet JM, et al. Lancet. 2003 Dec 6;362(9399):1907-17. doi: 10.1016/S0140-6736(03)14964-1. Lancet. 2003. PMID: 14667750 Review.
Resection is indicated among patients who have one tumour and well-preserved liver function. Liver transplantation benefits patients who have decompensated cirrhosis and one tumour smaller than 5 cm or three nodules smaller than 3 cm, but donor shortage greatly limi …
Resection is indicated among patients who have one tumour and well-preserved liver function. Liver transplantation benefits pa …
Cisplatin in Liver Cancer Therapy.
Hamaya S, Oura K, Morishita A, Masaki T. Hamaya S, et al. Int J Mol Sci. 2023 Jun 29;24(13):10858. doi: 10.3390/ijms241310858. Int J Mol Sci. 2023. PMID: 37446035 Free PMC article. Review.
Hepatocellular carcinoma (HCC) is the most common primary liver tumor and is often diagnosed at an unresectable advanced stage. ...TACE and HAIC have long been the standard of care for patients with unresectable HCC but are limited to the treatment of intrahe …
Hepatocellular carcinoma (HCC) is the most common primary liver tumor and is often diagnosed at an unresectable advanced stage …
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective.
Koga H, Iwamoto H, Suzuki H, Shimose S, Nakano M, Kawaguchi T. Koga H, et al. Clin Mol Hepatol. 2023 Apr;29(2):242-251. doi: 10.3350/cmh.2023.0102. Epub 2023 Mar 20. Clin Mol Hepatol. 2023. PMID: 36941079 Free PMC article. Review.
Striking advances in systemic therapy for unresectable advanced hepatocellular carcinoma (HCC) have improved the average prognosis of patients with HCC. ...
Striking advances in systemic therapy for unresectable advanced hepatocellular carcinoma (HCC) have improved the average prognosis of …
1,623 results